Join Now!
Home  Top Stories  Sports  Entertainment  Health News  Business  Personal Finance 
Real Estate  Business Finance  Insurance  Consulting 
Tax News  Forum
 

Writers






 


Featured Articles







BUSINESS



 




How much should you be saving on Health Insurance?

Cooking-free  gourmet frozen meals

Diet.com - What's Your Diet Personality?

120 x 60 Firm Tummy


Search:

 

Health

 

Vioxx Danger May Start Early and Last Long After Discontinued Use - Merck Disagrees With Interpretation - FDA Pos. Permanent Damage

May 19th 2006

Vioxx Danger May Start Early and Last Long After Discontinued Use - Merck Disagrees With Interpretation - FDA Pos. Permanent Damage

Vioxx

There appears to be more bad news for Merck & Co. after a Canadian Medical Association Journal said the drug may raise the risk of heart attack for patients who took Vioxx for less than 2 weeks.  Investigative journalist Evelyn Pringle reports that the study published online this month, found that more than 25% of 239 patients who had heart attacks did so in less than 13 days of being on the drug.

New reports indicate that patients that took the drug may have a higher risk of death for years after taking the drug.  A Reuters reports quotes Curt Furberg, a member of the US Food and Drug Administration's Drug Safety and Risk Management Advisory Committee, “It may be that Vioxx is causing permanent damage to the cardiovascular system, accelerating atherosclerosis or a sustained increase in blood pressure."

 

Furberg, a professor of public health at Wake Forest University, said his stroke concerns stem from a new 107-page report on patients who were followed for a year after they stopped taking Vioxx.

The dangers caused by Vioxx may begin early and may last long after use is stopped.  Joe Neel of NPR says the risk of heart attacks, strokes and serious peripheral vascular disorders began to increase soon after people started taking 25 mg of Vioxx each day.  It is unclear whether the 50mg dose was more or less dangerous than the 25mg dose.

 

Neel adds that the risk is difficult to determine because Merck & Co. has not released all of the data that were collected in the study, known by its acronym APPROVe (Adenomatous Polyp PRevention on Vioxx).

Merck disputes the new claims and disagrees with the interpretation. The company says that their APPROVe data show that cardiovascular problems occurred in patients who took Vioxx longer than 18 months. 

 

Neel says there are several conditions that have been associated with Vioxx use.  These problems include serious strokes, so-called "ministrokes" (also known as transient ischemic attacks), heart attacks, angina, congestive heart failure, coronary artery disease, phlebitis and other serious blockages of veins. 

 
Comment on this Article at our Forum

Submit your own Article

Heart Disease News

Pain and Arthritis Special Topic

  RSS Feed to Pain / Arthritis News

  RSS Feed to Heart Disease News

  RSS Feed to health News

  RSS Feed to all of our News

Add to Google Add to My AOL
Add to My Yahoo! Subscribe with Pluck RSS reader
Subscribe in NewsGator Online
Add this feed to Your C-Net
Subscribe in Bloglines Subscribe in Rojo

Dan Wilson
Best Syndication

Books on Heart Disease

Keywords and misspellings:  coranary micro-vascular disfunction iscemic iskemic ishcemic ishcemia angiograf blood presure stroke embolism imbolism embilism embelism bloode clot


Important:  The material on Best Syndication is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness program.
Google
 
Web BestSyndication.com

About   Contact   Site Map

Copyright 2005 Best Syndication                   Last Updated Sunday, July 13, 2008 12:24 AM